Hydrochloric Acid → HCID 178422083, 화합물

HRID 852797

반응식

HRID 852797 반응식
[CH:1]12[CH2:7][CH:4]([CH2:5][CH2:6]1)[CH2:3][C@@H:2]2[NH:8][C:9]1[S:10][C:11]([CH2:16][CH:17]2[CH2:22][CH2:21][N:20](C(OC(C)(C)C)=O)[CH2:19][CH2:18]2)([CH3:15])[C:12](=[O:14])[N:13]=1.Cl>CCOC(C)=O>[CH:1]12[CH2:7][CH:4]([CH2:5][CH2:6]1)[CH2:3][C@@H:2]2[NH:8][C:9]1[S:10][C:11]([CH3:15])([CH2:16][CH:17]2[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]2)[C:12](=[O:14])[N:13]=1

참가 물질

4

실험 절차

A mixture of tert-butyl 4-((2-((2S)-bicyclo[2.2.1]heptan-2-ylamino)-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl)methyl)piperidine-1-carboxylate (1.42 g, 3.37 mmol, 1.0 eq) in 50 mL of a 4.7 M HCl solution in EtOAc was stirred at room temperature. After 4 h, the reaction mixture was concentrated in vacuo. Aqueous Na2CO3 (2.0 M, 20 mL) was then added, and water was removed in vacuo. The residue was then triturated with 10% MeOH—CH2Cl2 (6×100 mL), and the combined triturating solution were concentrated in vacuo. The crude product was dissolved in CH2Cl2, filtered, and concentrated in vacuo to afford the title compound as a light orange solid (1.08 g). MS (ESI, pos. ion) m/z: 322 (M+H).

후처리

  1. concentrationthe reaction mixture was concentrated in vacuo
  2. additionAqueous Na2CO3 (2.0 M, 20 mL) was then added
  3. customwater was removed in vacuo
  4. customThe residue was then triturated with 10% MeOH—CH2Cl2 (6×100 mL)
  5. customthe combined triturating solution
  6. concentrationwere concentrated in vacuo
  7. dissolutionThe crude product was dissolved in CH2Cl2
  8. filtrationfiltered
  9. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-0e1563f55a5f4b9eaf5d515fa0a3be9d
출처 데이터셋
uspto-grants-2007_08
특허 번호
US07253196B2

연결된 노트

불러오는 중…